Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADE ...
Our kidneys are remarkable organs, silently working 24/7 to filter waste, regulate blood pressure, and produce essential hormones. Often, we don’t think about them until something goes wrong.
Men suffering from the disruptive symptoms of an enlarged prostate now have a new treatment option available at East Georgia Regional Medical Center. The hospital has introduced a state-of-the-art, ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Northampton Chronicle & Echo on MSN
West Northamptonshire grant helps bring life-changing pelvic floor therapy to community
A West Northamptonshire business owner recognised at this year’s Inspirational Women Awards is using the spotlight to shine a ...
Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results